ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 687669 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 687669; 2) Community: the network communities that were significantly associated with the response to NSC 687669; 3) Molecule: the relationships between components within communities and NSC 687669; 4) MDR: the compounds that were significantly associated with the NSC 687669.

NSC Compound Enrichment Correlation
NSC 302991 Camptothecin Derivative 0.0312262198176281 0.0097247598
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.0312262198176281 0.15076708
NSC 335794 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)butylidene]hydrazide 0.0312262198176281 -0.031196908
NSC 361667 Null 0.0312262198176281 0.023245556
NSC 4320 .beta.-k-Strophanthin 0.0312262198176281 -0.19717932
NSC 645892 Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 0.0312262198176281 -0.087449727
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.0312262198176281 -0.20729128
NSC 657751 Null 0.0312262198176281 0.092278938
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0312262198176281 0.067899174
NSC 666767 Null 0.0312262198176281 -0.13381369
Total:47  Current:32    [First] [Prev] [Next] [Last]